
CRSP
CRISPR Therapeutics AG
CRISPR Therapeutics develops gene-editing therapies, including programs for blood disorders and cancer.
Company website ↗Upcoming catalysts
Next 30 days- Dec 13, 2026zugocabtagene geleucel — relapsed/refractory B-cell malignanciesCompany release ↗
Phase 1/2 data